<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:04:57Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10487377" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10487377</identifier>
        <datestamp>2023-09-09</datestamp>
        <setSpec>lwwopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Circulation</journal-id>
              <journal-id journal-id-type="iso-abbrev">Circulation</journal-id>
              <journal-id journal-id-type="publisher-id">CIR</journal-id>
              <journal-title-group>
                <journal-title>Circulation</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0009-7322</issn>
              <issn pub-type="epub">1524-4539</issn>
              <publisher>
                <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
                <publisher-loc>Hagerstown, MD</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10487377</article-id>
              <article-id pub-id-type="pmcid">PMC10487377</article-id>
              <article-id pub-id-type="pmc-uid">10487377</article-id>
              <article-id pub-id-type="pmid">37555345</article-id>
              <article-id pub-id-type="pmid">37555345</article-id>
              <article-id pub-id-type="art-access-id">00002</article-id>
              <article-id pub-id-type="doi">10.1161/CIRCULATIONAHA.123.065300</article-id>
              <article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version>
              <article-categories>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>10001</subject>
                  <subject>10094</subject>
                  <subject>10149</subject>
                  <subject>10152</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6362-1291</contrib-id>
                  <name>
                    <surname>Perera</surname>
                    <given-names>Divaka</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6636-6174</contrib-id>
                  <name>
                    <surname>Morgan</surname>
                    <given-names>Holly P.</given-names>
                  </name>
                  <degrees>MBBCh</degrees>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <email>holly.p.morgan@kcl.ac.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ryan</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <email>matthew.dodd@lshtm.ac.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6207-6604</contrib-id>
                  <name>
                    <surname>Dodd</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref rid="aff3" ref-type="aff">3</xref>
                  <email>matthew.dodd@lshtm.ac.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1266-3288</contrib-id>
                  <name>
                    <surname>Clayton</surname>
                    <given-names>Tim</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref rid="aff3" ref-type="aff">3</xref>
                  <email>tim.lockie@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5245-4547</contrib-id>
                  <name>
                    <surname>Oâ€™Kane</surname>
                    <given-names>Peter D.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2861-0914</contrib-id>
                  <name>
                    <surname>Greenwood</surname>
                    <given-names>John P.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff5" ref-type="aff">5</xref>
                  <email>j.greenwood@leeds.ac.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Walsh</surname>
                    <given-names>Simon J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff6" ref-type="aff">6</xref>
                  <email>simon.j.walsh@icloud.com</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Weerackody</surname>
                    <given-names>Roshan</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff7" ref-type="aff">7</xref>
                  <email>roshan.weerackody@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McDiarmid</surname>
                    <given-names>Adam</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff8" ref-type="aff">8</xref>
                  <email>adam.mcdiarmid@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Amin-Youssef</surname>
                    <given-names>George</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff9" ref-type="aff">9</xref>
                  <email>george.amin-youssef@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0476-0886</contrib-id>
                  <name>
                    <surname>Strange</surname>
                    <given-names>Julian</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff10" ref-type="aff">10</xref>
                  <email>julian.strange@uhbristol.nhs.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Modi</surname>
                    <given-names>Bhavik</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff11" ref-type="aff">11</xref>
                  <email>bhavikmodi@hotmail.com</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lockie</surname>
                    <given-names>Timothy</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff12" ref-type="aff">12</xref>
                  <email>tim.lockie@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hogrefe</surname>
                    <given-names>Kai</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff13" ref-type="aff">13</xref>
                  <email>kai.hogrefe@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9769-0180</contrib-id>
                  <name>
                    <surname>Ahmed</surname>
                    <given-names>Fozia Z.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff14" ref-type="aff">14</xref>
                  <email>fozia.ahmed@mft.nhs.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Behan</surname>
                    <given-names>Miles</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff15" ref-type="aff">15</xref>
                  <email>milesbehan@hotmail.com</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jenkins</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff16" ref-type="aff">16</xref>
                  <email>n.jenkins2@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Abdelaal</surname>
                    <given-names>Eltigani</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff17" ref-type="aff">17</xref>
                  <email>eltigani.abdelaal@mft.nhs.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9400-7195</contrib-id>
                  <name>
                    <surname>Anderson</surname>
                    <given-names>Michelle</given-names>
                  </name>
                  <degrees>BA</degrees>
                  <xref rid="aff5" ref-type="aff">5</xref>
                  <email>michelle.anderson13@nhs.net</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1579-6294</contrib-id>
                  <name>
                    <surname>Watkins</surname>
                    <given-names>Stuart</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff18" ref-type="aff">18</xref>
                  <email>stuart.watkins@gjnh.scot.nhs.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Evans</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <degrees>BA</degrees>
                  <xref rid="aff3" ref-type="aff">3</xref>
                  <email>richard.evans@lshtm.ac.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rinaldi</surname>
                    <given-names>Christopher A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff2" ref-type="aff">2</xref>
                  <email>aldo.rinaldi@gstt.nhs.uk</email>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6333-9496</contrib-id>
                  <name>
                    <surname>Petrie</surname>
                    <given-names>Mark C.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff18" ref-type="aff">18</xref>
                  <email>mark.petrie@glasgow.ac.uk</email>
                </contrib>
                <on-behalf-of>for the REVIVED-BCIS2 Investigators</on-behalf-of>
                <xref rid="fn01" ref-type="fn">*</xref>
                <aff id="aff1">National Institute for Health Research Biomedical Research Center and British Heart Foundation Center of Research Excellence at the School of Cardiovascular Medicine and Sciences, Kingâ€™s College London, United Kingdom (D.P., H.P.M., M.R.).</aff>
                <aff id="aff2">Guyâ€™s and St Thomasâ€™ NHS Foundation Trust, London, United Kingdom (D.P., C.A.R.).</aff>
                <aff id="aff3">London School of Hygiene &amp; Tropical Medicine, United Kingdom (M.D., T.C., R.E.).</aff>
                <aff id="aff4">Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom (P.D.O.).</aff>
                <aff id="aff5">Leeds Teaching Hospitals NHS Trust and University of Leeds, United Kingdom (J.P.G., M.A.).</aff>
                <aff id="aff6">Belfast Health and Social Care NHS Trust, United Kingdom (S.J.W.).</aff>
                <aff id="aff7">Barts Health NHS Trust, London, United Kingdom (R.W.).</aff>
                <aff id="aff8">Newcastle Hospitals NHS Foundation Trust, United Kingdom (A.M.).</aff>
                <aff id="aff9">Kingâ€™s College Hospital NHS Foundation Trust, London, United Kingdom (G.A.-Y.).</aff>
                <aff id="aff10">University Hospitals Bristol NHS Foundation Trust, United Kingdom (J.S.).</aff>
                <aff id="aff11">University Hospitals of Leicester NHS Trust, United Kingdom (B.M.).</aff>
                <aff id="aff12">Royal Free Hospital, London, United Kingdom (T.L.).</aff>
                <aff id="aff13">Kettering General Hospital, Northampton, United Kingdom (K.H.).</aff>
                <aff id="aff14">Manchester Royal Infirmary, University NHS Foundation Trust, United Kingdom (F.Z.A.).</aff>
                <aff id="aff15">Edinburgh Royal Infirmary, United Kingdom (M.B.).</aff>
                <aff id="aff16">Sunderland Royal Hospital, United Kingdom (N.J.).</aff>
                <aff id="aff17">Wythenshawe Hospital, Manchester, United Kingdom (E.A.).</aff>
                <aff id="aff18">Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (S.W., M.C.P.).</aff>
              </contrib-group>
              <contrib-group content-type="collaborators">
                <contrib contrib-type="collab">
                  <name>
                    <surname>Perera</surname>
                    <given-names>Divaka</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Chiribiri</surname>
                    <given-names>Amedeo</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Carr-White</surname>
                    <given-names>Gerry</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pavlidis</surname>
                    <given-names>Antonis</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Redwood</surname>
                    <given-names>Simon</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Clapp</surname>
                    <given-names>Brian</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Rinaldi</surname>
                    <given-names>Aldo</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Rahman</surname>
                    <given-names>Haseeb</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Briceno</surname>
                    <given-names>Natalia</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Arnold</surname>
                    <given-names>Sophie</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Raynsford</surname>
                    <given-names>Amy</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wilson</surname>
                    <given-names>Karen</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Clack</surname>
                    <given-names>Lucy</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Petrie</surname>
                    <given-names>Mark</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McEntegart</surname>
                    <given-names>Margaret</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Watkins</surname>
                    <given-names>Stuart</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Shaukat</surname>
                    <given-names>Aadil</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Rocchiccioli</surname>
                    <given-names>Paul</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McAdam</surname>
                    <given-names>Marion</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McPherson</surname>
                    <given-names>Elizabeth</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cowan</surname>
                    <given-names>Louise</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wood</surname>
                    <given-names>Marie</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Weerackody</surname>
                    <given-names>Roshan</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Davies</surname>
                    <given-names>Ceri</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Smith</surname>
                    <given-names>Elliot</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Modi</surname>
                    <given-names>Bhavik</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mathew</surname>
                    <given-names>Bindu</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mitchelmore</surname>
                    <given-names>Oliver</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Adrego</surname>
                    <given-names>Rita</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Andiapen</surname>
                    <given-names>Mervyn</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Oâ€™Kane</surname>
                    <given-names>Peter</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Din</surname>
                    <given-names>Jehangir</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kennard</surname>
                    <given-names>Sarah</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Orr</surname>
                    <given-names>Sarah</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Purnell</surname>
                    <given-names>Cathie</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Greenwood</surname>
                    <given-names>John</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Blaxill</surname>
                    <given-names>Jonathan</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mozid</surname>
                    <given-names>Abdul</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Anderson</surname>
                    <given-names>Michelle</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Somers</surname>
                    <given-names>Kathryn</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Dixon</surname>
                    <given-names>Lana</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Walsh</surname>
                    <given-names>Simon</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Spence</surname>
                    <given-names>Mark</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Glover</surname>
                    <given-names>Patricia</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Brown</surname>
                    <given-names>Caroline</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Edwards</surname>
                    <given-names>Richard</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McDiarmid</surname>
                    <given-names>Adam</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Egred</surname>
                    <given-names>Mohaned</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Narytnyk</surname>
                    <given-names>Alla</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wealleans</surname>
                    <given-names>Vera</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Amin-Youssef</surname>
                    <given-names>George</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Shah</surname>
                    <given-names>Ajay</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McDonagh</surname>
                    <given-names>Theresa</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Byrne</surname>
                    <given-names>Jonathan</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pareek</surname>
                    <given-names>Nilesh</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Breeze</surname>
                    <given-names>Jonathan</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Antao</surname>
                    <given-names>Catherine</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>De Silva</surname>
                    <given-names>Kalpa</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Strange</surname>
                    <given-names>Julian</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Tom</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Nightingale</surname>
                    <given-names>Angus</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gallego</surname>
                    <given-names>Laura</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Medina</surname>
                    <given-names>Cristina</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gershlick</surname>
                    <given-names>Anthony</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McCann</surname>
                    <given-names>Gerald</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Ladwiniec</surname>
                    <given-names>Andrew</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Squire</surname>
                    <given-names>Iain</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Davison</surname>
                    <given-names>Joanna</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kenmuir-Hogg</surname>
                    <given-names>Kris</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Spratt</surname>
                    <given-names>James</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cosgrove</surname>
                    <given-names>Claudia</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Williams</surname>
                    <given-names>Rupert</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Firoozi</surname>
                    <given-names>Sam</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lim</surname>
                    <given-names>Pitt</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Bonato</surname>
                    <given-names>Giovanna</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sookhoo</surname>
                    <given-names>Vennessa</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Conway</surname>
                    <given-names>Dwayne</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Brooksby</surname>
                    <given-names>Paul</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wright</surname>
                    <given-names>Judith</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Exley</surname>
                    <given-names>Donna</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cotton</surname>
                    <given-names>James</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Horton</surname>
                    <given-names>Richard</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Metherell</surname>
                    <given-names>Stella</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Smallwood</surname>
                    <given-names>Andrew</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Hogrefe</surname>
                    <given-names>Kai</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cheng</surname>
                    <given-names>Adrian</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Beirnes</surname>
                    <given-names>Charmaine</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sidgwick</surname>
                    <given-names>Sian</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lockie</surname>
                    <given-names>Tim</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Patel</surname>
                    <given-names>Niket</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Rakhit</surname>
                    <given-names>Roby</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Davies</surname>
                    <given-names>Nina</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Smit</surname>
                    <given-names>Angelique</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Ahmed</surname>
                    <given-names>Fozia</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Hendry</surname>
                    <given-names>Cara</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Fath-Odoubadi</surname>
                    <given-names>Farzin</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Fraser</surname>
                    <given-names>Douglas</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mamas</surname>
                    <given-names>Mamas</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Oommen</surname>
                    <given-names>Anu</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Charles</surname>
                    <given-names>Thabitha</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Behan</surname>
                    <given-names>Miles</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Japp</surname>
                    <given-names>Alan</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Rif</surname>
                    <given-names>Belinda</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Jenkins</surname>
                    <given-names>Nicholas</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McClure</surname>
                    <given-names>Sam</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Oates</surname>
                    <given-names>Pauline</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Martin</surname>
                    <given-names>Karen</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Abdelaal</surname>
                    <given-names>Eltigani</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sarma</surname>
                    <given-names>Jaydeep</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Shastri</surname>
                    <given-names>Sanjay</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Riley</surname>
                    <given-names>Jo</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Giannopoulou</surname>
                    <given-names>Sarra</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Quinn</surname>
                    <given-names>Sophie</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Magapu</surname>
                    <given-names>Pradeep</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Stables</surname>
                    <given-names>Rod</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wright</surname>
                    <given-names>David</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Barton</surname>
                    <given-names>Janet</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Clarkson</surname>
                    <given-names>Nichola</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mahmoudi</surname>
                    <given-names>Michael</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Flett</surname>
                    <given-names>Andrew</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Curzen</surname>
                    <given-names>Nick</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Radmore</surname>
                    <given-names>Judith</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gough</surname>
                    <given-names>Sam</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Ludman</surname>
                    <given-names>Andrew</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kurdi</surname>
                    <given-names>Hibba</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Keenan</surname>
                    <given-names>Samantha</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Banerjee</surname>
                    <given-names>Prithwish</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Tapp</surname>
                    <given-names>Luke</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Edwards</surname>
                    <given-names>Nigel</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gibson</surname>
                    <given-names>Catherine</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kukreja</surname>
                    <given-names>Neville</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lynch</surname>
                    <given-names>Mary</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Barratt</surname>
                    <given-names>Claire</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>de Belder</surname>
                    <given-names>Mark</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Thambyrajah</surname>
                    <given-names>Jeet</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Swanson</surname>
                    <given-names>Neil</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Richardson</surname>
                    <given-names>Cath</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Atkinson</surname>
                    <given-names>Bev</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Viswanathan</surname>
                    <given-names>Girish</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Waugh</surname>
                    <given-names>Darren</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Routledge</surname>
                    <given-names>Helen</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Trevelyan</surname>
                    <given-names>Jasper</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Doughty</surname>
                    <given-names>Angela</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pegge</surname>
                    <given-names>Nick</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Dhamrait</surname>
                    <given-names>Sukhbir</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Moore</surname>
                    <given-names>Sally</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Galasko</surname>
                    <given-names>Gavin</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cassidy</surname>
                    <given-names>Christopher</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Waddington</surname>
                    <given-names>Natalia</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Edwards</surname>
                    <given-names>Tim</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Iqbal</surname>
                    <given-names>Javed</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Witherow</surname>
                    <given-names>Fraser</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Birch</surname>
                    <given-names>Jenny</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Munro</surname>
                    <given-names>Melanie</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wells</surname>
                    <given-names>Tim</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sinha</surname>
                    <given-names>Manas</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Frost</surname>
                    <given-names>Linda</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lee</surname>
                    <given-names>Kaeng</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Beattie</surname>
                    <given-names>James</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pitt</surname>
                    <given-names>Mike</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Chung</surname>
                    <given-names>Alan</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Ramcharitar</surname>
                    <given-names>Steve</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McCafferty</surname>
                    <given-names>Laura</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Martin</surname>
                    <given-names>Thomas</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Irving</surname>
                    <given-names>John</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Iskandar</surname>
                    <given-names>Zaid</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Hutcheon</surname>
                    <given-names>Anita</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gunn</surname>
                    <given-names>Julian</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Al-Mohammad</surname>
                    <given-names>Abdallah</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Agyemang</surname>
                    <given-names>Michael</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Griffiths</surname>
                    <given-names>Huw</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kalra</surname>
                    <given-names>Paul</given-names>
                    <prefix>Prof</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Howe</surname>
                    <given-names>Serena</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gray</surname>
                    <given-names>Tim</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sobolewska</surname>
                    <given-names>Jolanta</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Morby</surname>
                    <given-names>Louise</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Glover</surname>
                    <given-names>Jason</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Beynon</surname>
                    <given-names>James</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Knight</surname>
                    <given-names>Janet</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Das</surname>
                    <given-names>Paul</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Bellamy</surname>
                    <given-names>Chris</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Harman</surname>
                    <given-names>Emily</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pye</surname>
                    <given-names>Maurice</given-names>
                    <prefix>Mr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Megarry</surname>
                    <given-names>Simon</given-names>
                    <prefix>Dr</prefix>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McGill</surname>
                    <given-names>Yvonne</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Redfearn</surname>
                    <given-names>Heidi</given-names>
                  </name>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="c1">Correspondence to: Divaka Perera, MD, Cardiovascular Division, Kings College London, Rayne Institute, St Thomasâ€™ Hospital, London SE1 7EH, United Kingdom. Email <email xlink:href="divaka.perera@kcl.ac.uk">divaka.perera@kcl.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>09</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>12</day>
                <month>9</month>
                <year>2023</year>
              </pub-date>
              <volume>148</volume>
              <issue>11</issue>
              <fpage>862</fpage>
              <lpage>871</lpage>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Â© 2023 The Authors.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><italic toggle="yes">Circulation</italic> is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="cir-148-862.pdf"/>
              <abstract>
                <sec>
                  <title>BACKGROUND:</title>
                  <p>Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. Revascularization with coronary artery bypass graft or percutaneous coronary intervention is often recommended for these patients before implantation of a cardiac defibrillator because it is assumed that this may reduce the incidence of fatal and potentially fatal ventricular arrhythmias, although this premise has not been evaluated in a randomized trial to date.</p>
                </sec>
                <sec>
                  <title>METHODS:</title>
                  <p>Patients with severe left ventricular dysfunction, extensive coronary disease, and viable myocardium were randomly assigned to receive either percutaneous coronary intervention (PCI) plus optimal medical and device therapy (OMT) or OMT alone. The composite primary outcome was all-cause death or aborted sudden death (defined as an appropriate implantable cardioverter defibrillator therapy or a resuscitated cardiac arrest) at a minimum of 24 months, analyzed as time to first event on an intention-to-treat basis. Secondary outcomes included cardiovascular death or aborted sudden death, appropriate implantable cardioverter defibrillator (ICD) therapy or sustained ventricular arrhythmia, and number of appropriate ICD therapies.</p>
                </sec>
                <sec>
                  <title>RESULTS:</title>
                  <p>Between August 28, 2013, and March 19, 2020, 700 patients were enrolled across 40 centers in the United Kingdom. A total of 347 patients were assigned to the PCI+OMT group and 353 to the OMT alone group. The mean age of participants was 69 years; 88% were male; 56% had hypertension; 41% had diabetes; and 53% had a clinical history of myocardial infarction. The median left ventricular ejection fraction was 28%; 53.1% had an implantable defibrillator inserted before randomization or during follow-up. All-cause death or aborted sudden death occurred in 144 patients (41.6%) in the PCI group and 142 patients (40.2%) in the OMT group (hazard ratio, 1.03 [95% CI, 0.82â€“1.30]; <italic toggle="yes">P</italic>=0.80). There was no between-group difference in the occurrence of any of the secondary outcomes.</p>
                </sec>
                <sec>
                  <title>CONCLUSIONS:</title>
                  <p>PCI was not associated with a reduction in all-cause mortality or aborted sudden death. In patients with ischemic cardiomyopathy, PCI is not beneficial solely for the purpose of reducing potentially fatal ventricular arrhythmias.</p>
                </sec>
                <sec>
                  <title>REGISTRATION:</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; Unique identifier: NCT01920048.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>arrhythmias, cardiac</kwd>
                <kwd>cardiomyopathies</kwd>
                <kwd>death, sudden, cardiac</kwd>
                <kwd>defibrillators, implantable</kwd>
                <kwd>heart failure</kwd>
                <kwd>myocardial revascularization</kwd>
                <kwd>percutaneous coronary intervention</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>OPEN-ACCESS</meta-name>
                  <meta-value>TRUE</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>SDC</meta-name>
                  <meta-value>T</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text position="float">
              <caption>
                <title>Clinical Perspective</title>
              </caption>
              <sec>
                <title>What Is New?</title>
                <list list-type="bullet">
                  <list-item>
                    <p>The rate of death or aborted sudden death remains high in ischemic left ventricular dysfunction, despite the use of guideline-directed medical therapy.</p>
                  </list-item>
                  <list-item>
                    <p>Percutaneous coronary intervention was not associated with lower all-cause mortality, aborted sudden death, or sustained ventricular arrhythmias in patients with ischemic left ventricular dysfunction compared with optimal medical therapy alone.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>What Are the Clinical Implications?</title>
                <list list-type="bullet">
                  <list-item>
                    <p>Patients with ischemic left ventricular dysfunction should not undergo percutaneous coronary intervention with the sole aim of preventing the occurrence of ventricular arrhythmias.</p>
                  </list-item>
                  <list-item>
                    <p>In stable patients who are treated with guideline-directed medical therapy and meet criteria for implantable cardioverter defibrillator implantation, there is no evidence to support delaying implantation merely to assess the effect of percutaneous coronary intervention because the latter was not found to improve left ventricular function.</p>
                  </list-item>
                </list>
              </sec>
            </boxed-text>
            <p>Ischemic left ventricular systolic dysfunction is associated with significant morbidity and mortality. The leading cause of death in this population is sudden cardiac death, resulting largely from ventricular arrhythmias.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> Implantable cardioverter-defibrillators (ICDs) are widely used to mitigate the risk of sudden death in this population with primary prevention ICDs indicated in patients with a left ventricular ejection fraction &lt;35%.<sup><xref rid="R3" ref-type="bibr">3</xref></sup></p>
            <p>The generation of ventricular arrhythmias in this population is believed to relate to both myocardial scarring and inducible ischemia.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> Treating the latter with coronary revascularization (with coronary artery bypass graft [CABG] or percutaneous coronary intervention [PCI]) is assumed to lead to improvement in left ventricular ejection fraction, which underlies contemporary guidelines that recommend deferral of ICD implantation for up to 90 days after revascularization in a primary prevention setting.<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup> Despite widespread clinical adoption, no high-quality data exist to support this approach. The recently published REVIVED-BCIS2 trial (Revascularisation for Ischaemic Ventricular Dysfunctionâ€“British Cardiovascular Intervention Society 2 Trial) found that revascularization with PCI did not reduce the incidence of all-cause death or hospitalization for heart failure in patients with ischemic left ventricular dysfunction.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Among the subgroup who had an ICD or cardiac resynchronization therapy (CRT) defibrillator (CRT-D) implanted before randomization or within the first 90 days, those assigned to have PCI had fewer appropriate ICD therapies than those assigned to optimal medical therapy (OMT) alone, but this difference failed to reach statistical significance at 2 years. We now report the incidence of appropriate ICD therapies, resuscitated cardiac arrest, sustained ventricular arrhythmias, and death over the entire duration of follow-up in the PCI group compared with the group assigned to OMT alone.</p>
            <sec sec-type="methods">
              <title>METHODS</title>
              <sec>
                <title>Study Design</title>
                <p>The trial design and primary outcome results have been reported previously.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> In brief, REVIVED-BCIS2 was a prospective, randomized, multicenter open-label trial in which patients with ischemic left ventricular systolic dysfunction were randomized to receive either PCI plus OMT or OMT alone. Participants were recruited from 40 hospitals in the United Kingdom. The trial protocol was registered before enrollment of the first patient (URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>. Unique identifier: NCT01920048; URL: <ext-link xlink:href="https://www.isrctn.com" ext-link-type="uri">https://www.isrctn.com</ext-link>. Unique identifier: ISRCTN 45979711) and was approved by the UK Health Research Authority. All patients provided written informed consent.</p>
                <p>All participants enrolled in the REVIVED-BCIS2 trial were included in the present analyses. Patients were eligible for inclusion in the trial if they had ischemic left ventricular dysfunction, defined by the presence of severe left ventricular systolic dysfunction (left ventricular ejection fraction â‰¤35%), extensive coronary disease (British Cardiovascular Intervention Society Jeopardy Score â‰¥6), and evidence of viability in at least 4 dysfunctional myocardial segments that were amenable to revascularization with PCI. Those with myocardial infarction in the 4 weeks before randomization, sustained ventricular arrhythmia (ventricular tachycardia, ventricular fibrillation, or appropriate ICD discharges) in the 72 hours before randomization, or acutely decompensated heart failure were excluded.</p>
                <p>The statistical analysis plan for this arrhythmia substudy was finalized before unblinding of trial group data from the arrhythmia case report form and is included in the <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300" ext-link-type="uri">Supplemental Material</ext-link>. The data that support the findings of this study and the analytic methods will be made available 1 year from completion of the trial on reasonable request to the corresponding author.</p>
              </sec>
              <sec>
                <title>Randomization and Data Collection</title>
                <p>Participants were randomized in a 1:1 manner to either PCI plus OMT (PCI group) or OMT alone (OMT group). Randomization was stratified by center using randomly permuted blocks of varying size. Those randomized to the PCI group had revascularization attempted on all proximally diseased vessels subtending viable myocardium. All patients were initiated on OMT before enrollment, with subsequent uptitration of therapy supervised by a heart failure specialist at each recruiting site. Implantation of ICDs (and/or CRT) was an integral component of OMT in all patients, but the decision to implant a device was at the discretion of heart teams at recruiting centers. Device programming was carried out by implanting centers as per usual clinical care.</p>
                <p>Clinical follow-up was carried out for a minimum of 24 months, with the last follow-up visit conducted within 3 months of the end of the overall trial follow-up period. Transthoracic echocardiography was performed at 6 and 12 months and analyzed by an echocardiography core laboratory at Guyâ€™s and St Thomasâ€™ NHS Foundation Trust, with readers blinded to treatment allocation and the temporal sequence of echocardiograms. Data relating to indication and timing of ICD and CRT insertion, aborted sudden death, and sustained ventricular arrythmias were collected from a dedicated arrhythmia case report form after completion of main trial follow-up using physical and electronic health records at the participating centers, including all scheduled and unscheduled device checks. ICD therapies were classified as appropriate or inappropriate by recruiting centers, as documented in the clinical device interrogation reports; these are the reports used for clinical and governance purposes in the National Health Service of the United Kingdom.</p>
              </sec>
              <sec>
                <title>Outcomes</title>
                <p>The primary outcome was a composite of all-cause death or aborted sudden death (in turn, defined as an appropriate ICD therapy or a resuscitated cardiac arrest). Secondary outcomes included cardiovascular death or aborted sudden death, appropriate ICD therapy or sustained ventricular arrhythmia (any ventricular fibrillation or ventricular tachycardia &gt;100 beats per minute that lasts for &gt;30 seconds or requires termination in &lt;30 seconds as a result of hemodynamic compromise<sup><xref rid="R9" ref-type="bibr">9</xref></sup>), and total number of appropriate ICD therapies (classified as none, 1, or â‰¥2 therapies). Outcomes were assessed in all patients over a minimum follow-up period of 24 months, except when sustained ventricular arrhythmia was a component, when it was restricted to patients who had an ICD or CRT device in situ, either at randomization or inserted during trial follow-up. The cause of death was as adjudicated by an independent blinded clinical events committee; ICD-related outcomes were site reported. All outcomes are defined in <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300" ext-link-type="uri">Table S1</ext-link>.</p>
                <p>Analyses of the primary outcome were performed in these prespecified subgroups: device type (no device, CRT, non-CRT) indication for ICD (primary or secondary prevention), baseline left ventricular function, improvement in left ventricular function from baseline to 6 months (stratified by median change), extent of coronary artery disease, New York Heart Association functional class, and the type of recruiting center (dichotomized as centers that frequently/infrequently implanted ICDs or CRT devices in trial patients).</p>
              </sec>
              <sec sec-type="methods">
                <title>Statistical Methods</title>
                <p>Because this is a secondary analysis of a trial that has already been completed, a power calculation was not undertaken a priori. For illustration, if 40% of participants experience a primary outcome event over the entire duration of follow-up, equating to â‰ˆ250 events, the study would have at least 90% power to detect a hazard ratio of 0.65 or at least 80% power to detect a hazard ratio of 0.70, at a significance level of 5%.<sup><xref rid="R10" ref-type="bibr">10</xref></sup></p>
                <p>All analyses were performed on an intention-to-treat basis according to randomized assignment unless otherwise specified. The treatment groups were compared with a Cox proportional hazards model to calculate hazard ratios and 95% CIs. Unadjusted analyses were performed on the primary outcome, with time to first event measured from randomization to the date of death, withdrawal from the trial, or final trial follow-up. Adjusted analyses were also performed to account for variable timing of ICD or CRT implantation from randomization by including implantation as a time-varying covariate. Sensitivity analyses were performed on the primary outcome in the prespecified subgroup of patients who had an ICD or CRT device at randomization or received one within the first 90 days.</p>
                <p>The <italic toggle="yes">P</italic> value for the treatment difference was calculated with a likelihood ratio test. The proportionality assumption underlying the Cox model was assessed with Nelson-Aalen plots by treatment group. Cumulative event rates were calculated and presented with Kaplan-Meier time-to-event curves. All analyses were undertaken with STATA software, version 17 (Stata Corp). Categorical demographic data are presented as counts (percentages); continuous data are presented as means (SDs) or medians (interquartile ranges), depending on the normality of distribution.</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>RESULTS</title>
              <p>Between August 28, 2013, and March 19, 2020, 700 participants were enrolled; 347 were assigned to the PCI group and 353 to the OMT group (Figure <xref rid="F1" ref-type="fig">1</xref>). Primary outcome data at 2 years were available for 694 participants, with a median follow-up duration of 41 (27â€“60) months. Among the patients assigned to the PCI group, 334 (96.3%) underwent PCI at a median of 35 (15â€“57) days after randomization. In the OMT arm, 10.5% of patients underwent clinical events committeeâ€“adjudicated unplanned revascularization compared with 2.9% in the PCI arm. Detailed descriptions of the baseline assessments of left ventricular function and viability, titration of OMT, extent of coronary artery disease, and PCI procedural success have been reported previously.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Baseline clinical and demographic characteristics were evenly distributed between the groups (Table <xref rid="T1" ref-type="table">1</xref>).</p>
              <table-wrap position="float" id="T1">
                <label>Table 1.</label>
                <caption>
                  <p>Baseline Demographic and Clinical Characteristics of the Intention-to-Treat Population</p>
                </caption>
                <graphic xlink:href="cir-148-862-g001" position="float"/>
              </table-wrap>
              <fig position="float" id="F1">
                <label>Figure 1.</label>
                <caption>
                  <p><bold>CONSORT diagram.</bold> CAD indicates coronary artery disease; CONSORT, Consolidated Standards of Reporting Trials; CM, cardiomyopathy; LVSD, left ventricular systolic dysfunction; OMT, optimal medical therapy; and PCI, percutaneous coronary intervention. *Number screened and numbers excluded have been extrapolated from interval screening logs that were conducted during the trial at multiple centers.</p>
                </caption>
                <graphic xlink:href="cir-148-862-g002" position="float"/>
              </fig>
              <sec>
                <title>Primary Outcome</title>
                <p>The primary outcome of all-cause death or aborted sudden death occurred in 144 patients (41.6%) in the PCI group and 142 patients (40.2%) within the OMT group (unadjusted hazard ratio, 1.03 [95% CI, 0.82â€“1.30]; <italic toggle="yes">P</italic>=0.80); adjusted hazard ratio, 1.02 [95% CI, 0.81â€“1.29]; <italic toggle="yes">P</italic>=0.84; Figure <xref rid="F2" ref-type="fig">2</xref>). There were 110 deaths (31.8%) in the PCI group and 115 (32.6%) in the OMT group. Aborted sudden death occurred in 44 patients (12.7%) in the PCI group and 47 patients (13.3%) in the OMT group (Table <xref rid="T2" ref-type="table">2</xref>). The treatment effect for the primary outcome was consistent across all prespecified subgroups (Figure <xref rid="F3" ref-type="fig">3</xref>).</p>
                <table-wrap position="float" id="T2">
                  <label>Table 2.</label>
                  <caption>
                    <p>Primary and Secondary Outcomes Over All Follow-Up</p>
                  </caption>
                  <graphic xlink:href="cir-148-862-g003" position="float"/>
                </table-wrap>
                <fig position="float" id="F2">
                  <label>Figure 2.</label>
                  <caption>
                    <p><bold>Primary outcome of all-cause death or aborted sudden death over all follow-up.</bold> Kaplan-Meier estimates of the cumulative incidence of death from any cause or aborted sudden death in a time-to-first event analysis. Incidence includes total events over the entire follow-up period in each group in the intention-to-treat population, censored at death, withdrawal from the trial, or date of final follow-up encounter. HR indicates hazard ratio; OMT, optimal medical therapy; and PCI, percutaneous coronary intervention.</p>
                  </caption>
                  <graphic xlink:href="cir-148-862-g004" position="float"/>
                </fig>
                <fig position="float" id="F3">
                  <label>Figure 3.</label>
                  <caption>
                    <p><bold>Primary outcome by prespecified subgroups.</bold> Forest plot showing hazard ratios for the primary outcome according to prespecified subgroups. Dashed line represents the null hypothesis of no treatment effect. The British Cardiovascular Intervention Society Jeopardy Score ranges from 0 to 12, with higher scores indicating a greater volume of myocardium subtended by diseased arteries. Implantable cardioverter defibrillator (ICD) indication (primary or secondary) includes both ICD and cardiac resynchronization therapy defibrillator implantations. Left ventricular ejection fraction (LVEF) change is from baseline to 6 months from core laboratory analyses; improved LVEF was defined as an improvement above the median change (&gt;4.2%); unchanged or deteriorated LVEF was defined as below the median (â‰¤4.2%). Recruiting center type defined by frequency of device implantation in the REVIVED-BCIS2 trial (Revascularisation for Ischaemic Ventricular Dysfunction): frequent if &gt;50% of patients received a device, and infrequent if â‰¤50% received a device. NYHA indicates New York Heart Association heart failure class; OMT, optimal medical therapy; and PCI, percutaneous coronary intervention.</p>
                  </caption>
                  <graphic xlink:href="cir-148-862-g005" position="float"/>
                </fig>
              </sec>
              <sec>
                <title>Secondary Outcomes</title>
                <p>The secondary outcome of cardiovascular death or aborted sudden death occurred in 111 of 346 patients in the PCI group and 120 of 353 in the OMT group (32.1% versus 34.0%; hazard ratio, 0.94 [95% CI, 0.73â€“1.22]). The composite of appropriate therapy or sustained ventricular arrhythmia occurred in 47 of 174 patients in the PCI group (27.0%) and 56 of 197 patients in the OMT group (28.4%; hazard ratio, 0.87 [95% CI, 0.59â€“1.28]; <italic toggle="yes">P</italic>=0.47). There was no between-group difference in the total number of appropriate ICD therapies (odds ratio, 1.11 [95% CI, 0.68â€“1.80]; <italic toggle="yes">P</italic>=0.68; Table <xref rid="T2" ref-type="table">2</xref>).</p>
                <p>A total of 371 patients (53.1%) had an ICD or CRT device inserted before randomization or during follow-up: 174 of 347 (50.3%) in the PCI group and 197 of 353 (55.8%) in the OMT group (difference, âˆ’5.5% [95% CI, âˆ’12.9% to 1.9%]; Figure <xref rid="F4" ref-type="fig">4</xref> and <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300" ext-link-type="uri">Table S2</ext-link>). The sensitivity analyses restricted to patients who had an ICD or CRT device in situ at randomization or received one within 90 days yielded results similar to those of the main analyses for the primary outcome (58 [47.2%] versus 62 [50.8%]; hazard ratio, 0.82 [95% CI, 0.57â€“1.18]; <italic toggle="yes">P</italic>=0.29) and the secondary outcomes (<ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300" ext-link-type="uri">Tables S3 and S4</ext-link>).</p>
                <fig position="float" id="F4">
                  <label>Figure 4.</label>
                  <caption>
                    <p><bold>Cumulative device implantation by treatment group.</bold> The proportional hazards assumption seems to be violated (demonstrated by early separation of the curves, followed by gradual convergence over time); hence, a hazard ratio has not been calculated. OMT indicates optimal medical therapy; and PCI, percutaneous coronary intervention.</p>
                  </caption>
                  <graphic xlink:href="cir-148-862-g006" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>DISCUSSION</title>
              <p>In this analysis of the REVIVED-BCIS2 trial, a strategy of PCI in addition to OMT was not associated with a reduction in all-cause mortality or aborted sudden death in patients with ischemic left ventricular dysfunction. Furthermore, PCI was not associated with a reduction in the incidence of sustained ventricular arrhythmias or appropriate ICD therapies. The results suggest that patients with stable ischemic left ventricular dysfunction who are on guideline-directed medical therapy should not undergo PCI with the sole aim of reducing potentially fatal arrhythmias. The findings also challenge the widespread practice of undertaking CABG or PCI in most patients who are candidates for ICD implantation<sup><xref rid="R11" ref-type="bibr">11</xref></sup> to reduce the arrhythmic risk, an effect believed be mediated by an improvement in left ventricular function. The absence of incremental improvement in left ventricular function in this cohort as a whole<sup><xref rid="R7" ref-type="bibr">7</xref></sup> may also partly explain why PCI was not associated with a reduction in death or aborted sudden death in our study. The 2021 American College of Cardiology/American Heart Association guidelines recommend that revascularization should not be undertaken with the sole purpose of preventing recurrent sustained monomorphic ventricular tachycardia that is suspected to be related to scar.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> Our findings now extend this recommendation to the larger group of patients in whom ICD implantation is considered on primary prevention grounds.</p>
              <p>In the preliminary report of the REVIVED-BCIS2 trial, appropriate ICD therapies tended to be less frequently observed at 2 years in patients assigned to have PCI, in the subgroup who had a device implanted at baseline or within the first 90 days.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> The current report extends arrhythmia follow-up of this subgroup and reveals that, when the entire duration of the trial is considered and competing mortality is accounted for, PCI is not associated with a reduction in aborted sudden death. This is consistent with the occurrence of the primary outcome in the entire trial cohort, which was not different between treatment arms. The recruited population was younger than the median age of patients newly diagnosed with heart failure in the United Kingdom<sup><xref rid="R13" ref-type="bibr">13</xref></sup> but older than in other randomized trials in this field (mean ages: MADIT II [Multicenter Automatic Defibrillator Implantation 2 Trial], 64 years; MUSTT [Multicenter Unsustained Tachycardia Trial], 67 years; PROTECT-II [Prospective, Multi-center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump [IABP] in Patients Undergoing Non Emergent High Risk PCI], 68 years; DAPA HF [Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial], 66 years; CABG PATCH [Coronary Artery Bypass Graft Patch], 63 years; DANISH [Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality], 63 years; STICH [Surgical Treatment for Ischemic Heart Failure Trial], 59 years; REVIVED-BCIS 2, 70 years).<sup><xref rid="R14" ref-type="bibr">14</xref>â€“<xref rid="R20" ref-type="bibr">20</xref></sup></p>
              <p>To the best of our knowledge, ours is the first trial to assess the effect of randomized allocation to PCI on arrhythmic risk in patients with stable ischemic left ventricular dysfunction. In the CABG PATCH trial, patients with ischemic left ventricular dysfunction and no history of ventricular arrhythmia who were undergoing CABG were randomized to receive either a surgically implanted ICD or no ICD; at an average follow-up of 32 months, there was no significant difference in all-cause mortality between groups.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> The authors hypothesized that the provision of CABG in both arms of the trial reduced the incidence of ventricular arrhythmias to the extent that the incremental benefit of ICD implantation was lost, but they were not able to confirm or refute this hypothesis because there was no medical therapy arm in that trial. In the STICH trial, which randomized patients with ischemic left ventricular dysfunction to either CABG or OMT, there was a significant reduction in the occurrence of sudden death in the CABG group.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> There was, however, a low rate of ICD or CRT implantation. Data on nonfatal ventricular arrhythmias were not captured, and the authors were unable to distinguish between sudden deaths due to ventricular arrhythmia from those caused by acute myocardial infarction or other causes.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup></p>
              <p>Site-reported completeness of revascularization in the REVIVED-BCIS2 trial was high, which would be expected to appreciably reduce the burden of inducible ischemia, particularly because the protocol recommended revascularization of all diseased vessels subtending viable myocardium. In this context, the inability to reduce all-cause mortality or aborted sudden death with PCI may indicate that ischemia is less important in the genesis of ventricular arrhythmias than scar, although the relative importance of these 2 factors cannot be definitively discerned without information on the burden and distribution of each. Furthermore, we cannot discount the possibility that PCI may cause periprocedural infarction, which could partially offset the benefit of reducing ischemic burden.<sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup> Core laboratoryâ€“reported angiographic data are pending and may also provide further insights.</p>
              <p>Our findings support those of the ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) investigators, who found no difference in all-cause mortality between patients with documented ischemia who underwent revascularization and those treated with medical therapy alone, although that trial excluded patients with impaired left ventricular function.<sup><xref rid="R26" ref-type="bibr">26</xref></sup></p>
              <p>Our study has some limitations. Because more than half of all patients received an ICD or CRT device, the trial has provided important insights into the potential mechanism of death and aborted sudden death in these cases, however, we had less ability to capture nonfatal arrhythmias in patients without devices and may have underestimated the overall event rate. This may have reduced statistical power, but given that the proportions of patients with devices were similar in the 2 trial groups, our estimation of treatment effect is unlikely to have been affected. The number of events detected provides 85% power to detect or exclude a hazard ratio of 0.70, in line with our initial power calculation, although we cannot exclude a smaller treatment effect with PCI. Second, the decision to implant a device was at the discretion of treating physicians and was based on clinical factors and regional differences in policy. Although there was no significant difference in the overall rates of device implantation over the course of the trial, it should be noted that the timing of implantation was not identical in both groups (Figure <xref rid="F4" ref-type="fig">4</xref>), although analyses adjusted for the timing of implantation and sensitivity analyses of patients with devices in situ at randomization provided conclusions similar to those of the unadjusted analyses. Third, the a priori definition of aborted sudden death included antitachycardia pacing or shocks, but we cannot be certain that all ICD therapies were delivered to treat arrhythmias that would have had fatal consequences without such therapies.<sup><xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup> Fourth, the protocol did not mandate postmortem interrogation of ICDs; although this does not affect the primary outcome, it is possible that we may have underestimated the frequency of sustained ventricular arrhythmias in both groups. Last, the classification of appropriate and inappropriate ICD therapy was based on the diagnoses recorded by the clinical teams at recruiting centers, and it is possible that device technicians and electrophysiologists may have been aware of the treatment assignment, so we cannot exclude ascertainment bias.</p>
              <sec sec-type="conclusions">
                <title>Conclusions</title>
                <p>In patients with ischemic left ventricular dysfunction, a strategy of PCI plus OMT was not associated with a reduction in death or aborted sudden death compared with a strategy of OMT alone. Patients with stable ischemic cardiomyopathy should not undergo PCI solely to reduce the burden of arrhythmias, and in patients who are eligible for an ICD, implantation does not need to be deferred until revascularization has been performed.</p>
              </sec>
            </sec>
            <sec>
              <title>ARTICLE INFORMATION</title>
              <sec>
                <title>Sources of Funding</title>
                <p>The trial was sponsored by Kingâ€™s College London and funded by the National Institute for Health and Care Research Health Technology Assessment Program. The arrhythmia analyses were supported by the British Heart Foundation (fellowship FS/CRTF/21/24190 and the Kingâ€™s British Heart Foundation Center of Research Excellence grant RE/18/2/34213).</p>
              </sec>
              <sec sec-type="COI-statement">
                <title>Disclosures</title>
                <p>None.</p>
              </sec>
              <sec>
                <title>Supplemental Material</title>
                <p>REVIVED-BCIS2 sites and investigators</p>
                <p>Trial organization and oversight</p>
                <p>Tables S1â€“S4</p>
                <p>REVIVED-BCIS2 Arrhythmia Study statistical analysis plan</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="SD1" position="float" content-type="local-data">
                <media id="s1" content-type="document" xlink:href="cir-148-862-s001.pdf" position="anchor"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="abbr">
                <p>
                  <def-list>
                    <title>Nonstandard Abbreviations and Acronyms</title>
                    <def-item>
                      <term>CABG</term>
                      <def>
                        <p>coronary artery bypass graft</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>CABG PATCH</term>
                      <def>
                        <p>Coronary Artery Bypass Graft Patch</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>CRT</term>
                      <def>
                        <p>cardiac resynchronization therapy</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>CRT-D</term>
                      <def>
                        <p>cardiac resynchronization therapy defibrillator</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>DANISH</term>
                      <def>
                        <p>Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>DAPA HF</term>
                      <def>
                        <p>Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>ICD</term>
                      <def>
                        <p>implantable cardioverter-defibrillator</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>ISCHEMIA</term>
                      <def>
                        <p>International Study of Comparative Health Effectiveness With Medical and Invasive Approaches</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>MADIT II</term>
                      <def>
                        <p>Multicenter Automatic Defibrillator Implantation 2 Trial</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>MUSTT</term>
                      <def>
                        <p>Multicenter Unsustained Tachycardia Trial</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>OMT</term>
                      <def>
                        <p>optimal medical therapy</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>PCI</term>
                      <def>
                        <p>percutaneous coronary intervention</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>PROTECT-II</term>
                      <def>
                        <p>Prospective, Multi-center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump [IABP] in Patients Undergoing Non Emergent High Risk PCI</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>REVIVED-BCIS2</term>
                      <def>
                        <p>Revascularisation for Ischaemic Ventricular Dysfunctionâ€“British Cardiovascular Intervention Society 2 Trial</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>STICH</term>
                      <def>
                        <p>Surgical Treatment for Ischemic Heart Failure Trial</p>
                      </def>
                    </def-item>
                  </def-list>
                </p>
              </fn>
            </fn-group>
            <fn-group>
              <fn fn-type="other" id="fn01">
                <label>*</label>
                <p>A list of all REVIVED-BCIS2 investigators is given in the Appendix.</p>
              </fn>
              <fn fn-type="supplementary-material">
                <p>Supplemental Material is available at <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/circulationaha.123.065300</ext-link>.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p>For Sources of Funding and Disclosures, see page 870</p>
              </fn>
              <fn fn-type="other">
                <p><italic toggle="yes">Circulation</italic> is available at <ext-link xlink:href="www.ahajournals.org/journal/circ" ext-link-type="uri">www.ahajournals.org/journal/circ</ext-link></p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="R1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GrÃ¤ni</surname><given-names>C</given-names></name><name><surname>Benz</surname><given-names>DC</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Windecker</surname><given-names>S</given-names></name><name><surname>Kwong</surname><given-names>RY</given-names></name></person-group>. <article-title>Sudden cardiac death in ischemic heart disease: from imaging arrhythmogenic substrate to guiding therapies.</article-title><source>JACC Cardiovasc Imaging</source>. <year>2020</year>;<volume>13</volume>:<fpage>2223</fpage>â€“<lpage>2238</lpage>. <comment>doi: 10.1016/j.jcmg.2019.10.021</comment><pub-id pub-id-type="pmid">31864982</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>H</given-names></name><name><surname>Petrie</surname><given-names>MC</given-names></name><name><surname>Perera</surname><given-names>D</given-names></name></person-group>. <article-title>Coronary revascularisation in patients with ischaemic cardiomyopathy.</article-title><source>Heart</source>. <year>2021</year>;<volume>107</volume>:<fpage>612</fpage>â€“<lpage>618</lpage>. <comment>doi: 10.1136/heartjnl-2020-316856</comment><pub-id pub-id-type="pmid">33436491</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3.</label>
                <mixed-citation publication-type="webpage"><collab>National Institute for Health and Care Excellence</collab>. <article-title>Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure. Technology appraisal guidance [TA314].</article-title> June 25, <year>2014</year>. <comment>Accessed May 6, 2023. <ext-link xlink:href="https://www.nice.org.uk/guidance/ta314" ext-link-type="uri">https://www.nice.org.uk/guidance/ta314</ext-link></comment></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canty</surname><given-names>JM</given-names></name><name><surname>Suzuki</surname><given-names>G</given-names></name><name><surname>Banas</surname><given-names>MD</given-names></name><name><surname>Verheyen</surname><given-names>F</given-names></name><name><surname>Borgers</surname><given-names>M</given-names></name><name><surname>Fallavollita</surname><given-names>JA</given-names></name></person-group>. <article-title>Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death.</article-title><source>Circ Res</source>. <year>2004</year>;<volume>94</volume>:<fpage>1142</fpage>â€“<lpage>1149</lpage>. <comment>doi: 10.1161/01.RES.0000125628.57672.CF</comment><pub-id pub-id-type="pmid">15016734</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AM</given-names></name><name><surname>Stainback</surname><given-names>RF</given-names></name><name><surname>Bailey</surname><given-names>SR</given-names></name><name><surname>Epstein</surname><given-names>AE</given-names></name><name><surname>Heidenreich</surname><given-names>PA</given-names></name><name><surname>Jessup</surname><given-names>M</given-names></name><name><surname>Kapa</surname><given-names>S</given-names></name><name><surname>Kremers</surname><given-names>MS</given-names></name><name><surname>Lindsay</surname><given-names>BD</given-names></name><name><surname>Stevenson</surname><given-names>LW</given-names></name></person-group>. <article-title>ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.</article-title><source>Heart Rhythm</source>. <year>2013</year>;<volume>10</volume>:<fpage>e11</fpage>â€“<lpage>e58</lpage>. <comment>doi: 10.1016/j.hrthm.2013.01.008</comment><pub-id pub-id-type="pmid">23473952</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khatib</surname><given-names>SM</given-names></name><name><surname>Stevenson</surname><given-names>WG</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Bryant</surname><given-names>WJ</given-names></name><name><surname>Callans</surname><given-names>DJ</given-names></name><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Deal</surname><given-names>BJ</given-names></name><name><surname>Dickfeld</surname><given-names>T</given-names></name><name><surname>Field</surname><given-names>ME</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><etal/></person-group>. <article-title>2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title><source>Circulation</source>. <year>2018</year>;<volume>138</volume>:<fpage>e272</fpage>â€“<lpage>e391</lpage>. <comment>doi: 10.1161/CIR.0000000000000549</comment><pub-id pub-id-type="pmid">29084731</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>D</given-names></name><name><surname>Clayton</surname><given-names>T</given-names></name><name><surname>Oâ€™Kane</surname><given-names>PD</given-names></name><name><surname>Greenwood</surname><given-names>JP</given-names></name><name><surname>Weerackody</surname><given-names>R</given-names></name><name><surname>Ryan</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>HP</given-names></name><name><surname>Dodd</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Canter</surname><given-names>R</given-names></name><etal/></person-group>; <collab>REVIVED-BCIS2 Investigators</collab>. <article-title>Percutaneous revascularization for ischemic left ventricular dysfunction.</article-title><source>N Engl J Med</source>. <year>2022</year>;<volume>387</volume>:<fpage>1351</fpage>â€“<lpage>1360</lpage>. <comment>doi: 10.1056/NEJMoa2206606</comment><pub-id pub-id-type="pmid">36027563</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>D</given-names></name><name><surname>Clayton</surname><given-names>T</given-names></name><name><surname>Petrie</surname><given-names>MC</given-names></name><name><surname>Greenwood</surname><given-names>JP</given-names></name><name><surname>Oâ€™Kane</surname><given-names>PD</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Sculpher</surname><given-names>M</given-names></name><name><surname>Mcdonagh</surname><given-names>T</given-names></name><name><surname>Gershlick</surname><given-names>A</given-names></name><name><surname>de Belder</surname><given-names>M</given-names></name><etal/></person-group>; <collab>REVIVED Investigators</collab>. <article-title>Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy.</article-title><source>JACC Heart Fail</source>. <year>2018</year>;<volume>6</volume>:<fpage>517</fpage>â€“<lpage>526</lpage>. <comment>doi: 10.1016/j.jchf.2018.01.024</comment><pub-id pub-id-type="pmid">29852933</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxton</surname><given-names>AE</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Callans</surname><given-names>DJ</given-names></name><name><surname>DiMarco</surname><given-names>JP</given-names></name><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Greene</surname><given-names>HL</given-names></name><name><surname>Haines</surname><given-names>DE</given-names></name><name><surname>Hayes</surname><given-names>DL</given-names></name><name><surname>Heidenreich</surname><given-names>PA</given-names></name><name><surname>Miller</surname><given-names>JM</given-names></name><etal/></person-group>; <collab>American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology)</collab>. <article-title>ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology).</article-title><source>Circulation</source>. <year>2006</year>;<volume>114</volume>:<fpage>2534</fpage>â€“<lpage>2570</lpage>. <comment>doi: 10.1161/CIRCULATIONAHA.106.180199</comment><pub-id pub-id-type="pmid">17130345</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Clayton</surname><given-names>TC</given-names></name><name><surname>Stone</surname><given-names>GW</given-names></name></person-group>. <article-title>Design of major randomized trials: part 3 of a 4-part series on statistics for clinical trials.</article-title><source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>66</volume>:<fpage>2757</fpage>â€“<lpage>2766</lpage>. <comment>doi: 10.1016/j.jacc.2015.10.036</comment><pub-id pub-id-type="pmid">26700838</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>FJ</given-names></name><name><surname>Sousa-Uva</surname><given-names>M</given-names></name><name><surname>Ahlsson</surname><given-names>A</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Banning</surname><given-names>AP</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><name><surname>Byrne</surname><given-names>RA</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><name><surname>Head</surname><given-names>SJ</given-names></name><etal/></person-group>; <collab>ESC Scientific Document Group</collab>. <article-title>2018 ESC/EACTS guidelines on myocardial revascularization.</article-title><source>Eur Heart J</source>. <year>2019</year>;<volume>40</volume>:<fpage>87</fpage>â€“<lpage>165</lpage>. <comment>doi: 10.1093/eurheartj/ehy394</comment><pub-id pub-id-type="pmid">30165437</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawton</surname><given-names>JS</given-names></name><name><surname>Tamis-Holland</surname><given-names>JE</given-names></name><name><surname>Bangalore</surname><given-names>S</given-names></name><name><surname>Bates</surname><given-names>ER</given-names></name><name><surname>Beckie</surname><given-names>TM</given-names></name><name><surname>Bischoff</surname><given-names>JM</given-names></name><name><surname>Bittl</surname><given-names>JA</given-names></name><name><surname>Cohen</surname><given-names>MG</given-names></name><name><surname>DiMaio</surname><given-names>JM</given-names></name><name><surname>Don</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</article-title><source>Circulation</source>. <year>2022</year>;<volume>145</volume>:<fpage>e18</fpage>â€“<lpage>e114</lpage>. <comment>doi: 10.1161/CIR.0000000000001038</comment><pub-id pub-id-type="pmid">34882435</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13.</label>
                <mixed-citation publication-type="book"><collab>NICOR</collab>. <article-title>National Heart Failure Audit (NHFA): 2020 summary report (2018/19 Data).</article-title><publisher-name>Healthcare Quality Improvement Partnership</publisher-name>. June 5, <year>2020</year>. <comment>Accessed 6 May 6, 2023. <ext-link xlink:href="https://www.nicor.org.uk/wp-content/uploads/2020/12/National-Heart-Failure-Audit-2020-FINAL.pdf" ext-link-type="uri">https://www.nicor.org.uk/wp-content/uploads/2020/12/National-Heart-Failure-Audit-2020-FINAL.pdf</ext-link></comment></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Zareba</surname><given-names>W</given-names></name><name><surname>Hall</surname><given-names>WJ</given-names></name><name><surname>Klein</surname><given-names>H</given-names></name><name><surname>Wilber</surname><given-names>DJ</given-names></name><name><surname>Cannom</surname><given-names>DS</given-names></name><name><surname>Daubert</surname><given-names>JP</given-names></name><name><surname>Higgins</surname><given-names>SL</given-names></name><name><surname>Brown</surname><given-names>MW</given-names></name><name><surname>Andrews</surname><given-names>ML</given-names></name></person-group>; <collab>Multicenter Automatic Defibrillator Implantation Trial II Investigators</collab>. <article-title>Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.</article-title><source>N Engl J Med</source>. <year>2002</year>;<volume>346</volume>:<fpage>877</fpage>â€“<lpage>883</lpage>. <comment>doi: 10.1056/NEJMoa013474</comment><pub-id pub-id-type="pmid">11907286</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxton</surname><given-names>AE</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Josephson</surname><given-names>ME</given-names></name><name><surname>Prystowsky</surname><given-names>EN</given-names></name><name><surname>Hafley</surname><given-names>G</given-names></name></person-group>. <article-title>A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial investigators.</article-title><source>N Engl J Med</source>. <year>1999</year>;<volume>341</volume>:<fpage>1882</fpage>â€“<lpage>1890</lpage>. <comment>doi: 10.1056/NEJM199912163412503</comment><pub-id pub-id-type="pmid">10601507</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oâ€™Neill</surname><given-names>WW</given-names></name><name><surname>Kleiman</surname><given-names>NS</given-names></name><name><surname>Moses</surname><given-names>J</given-names></name><name><surname>Henriques</surname><given-names>JP</given-names></name><name><surname>Dixon</surname><given-names>S</given-names></name><name><surname>Massaro</surname><given-names>J</given-names></name><name><surname>Palacios</surname><given-names>I</given-names></name><name><surname>Maini</surname><given-names>B</given-names></name><name><surname>Mulukutla</surname><given-names>S</given-names></name><name><surname>DzavÃ­k</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.</article-title><source>Circulation</source>. <year>2012</year>;<volume>126</volume>:<fpage>1717</fpage>â€“<lpage>1727</lpage>. <comment>doi: 10.1161/CIRCULATIONAHA.112.098194</comment><pub-id pub-id-type="pmid">22935569</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>JJV</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Inzucchi</surname><given-names>SE</given-names></name><name><surname>KÃ¸ber</surname><given-names>L</given-names></name><name><surname>Kosiborod</surname><given-names>MN</given-names></name><name><surname>Martinez</surname><given-names>FA</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Sabatine</surname><given-names>MS</given-names></name><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>BÄ›lohlÃ¡vek</surname><given-names>J</given-names></name><etal/></person-group>; <collab>DAPA-HF Trial Committees and Investigators</collab>. <article-title>Dapagliflozin in patients with heart failure and reduced ejection fraction.</article-title><source>N Engl J Med</source>. <year>2019</year>;<volume>381</volume>:<fpage>1995</fpage>â€“<lpage>2008</lpage>. <comment>doi: 10.1056/NEJMoa1911303</comment><pub-id pub-id-type="pmid">31535829</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigger</surname><given-names>JT</given-names></name></person-group>. <article-title>Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery: Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.</article-title><source>N Engl J Med</source>. <year>1997</year>;<volume>337</volume>:<fpage>1569</fpage>â€“<lpage>1575</lpage>. <comment>doi: 10.1056/NEJM199711273372201</comment><pub-id pub-id-type="pmid">9371853</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>KÃ¸ber</surname><given-names>L</given-names></name><name><surname>Thune</surname><given-names>JJ</given-names></name><name><surname>Nielsen</surname><given-names>JC</given-names></name><name><surname>Haarbo</surname><given-names>J</given-names></name><name><surname>VidebÃ¦k</surname><given-names>L</given-names></name><name><surname>Korup</surname><given-names>E</given-names></name><name><surname>Jensen</surname><given-names>G</given-names></name><name><surname>Hildebrandt</surname><given-names>P</given-names></name><name><surname>Steffensen</surname><given-names>FH</given-names></name><name><surname>Bruun</surname><given-names>NE</given-names></name><etal/></person-group>; <collab>DANISH Investigators</collab>. <article-title>Defibrillator implantation in patients with nonischemic systolic heart failure.</article-title><source>N Engl J Med</source>. <year>2016</year>;<volume>375</volume>:<fpage>1221</fpage>â€“<lpage>1230</lpage>. <comment>doi: 10.1056/NEJMoa1608029</comment><pub-id pub-id-type="pmid">27571011</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velazquez</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Deja</surname><given-names>MA</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Sopko</surname><given-names>G</given-names></name><name><surname>Marchenko</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>IS</given-names></name><name><surname>Pohost</surname><given-names>G</given-names></name><name><surname>Gradinac</surname><given-names>S</given-names></name><name><surname>Abraham</surname><given-names>WT</given-names></name><etal/></person-group>; <collab>STICH Investigators</collab>. <article-title>Coronary-artery bypass surgery in patients with left ventricular dysfunction.</article-title><source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>:<fpage>1607</fpage>â€“<lpage>1616</lpage>. <comment>doi: 10.1056/NEJMoa1100356</comment><pub-id pub-id-type="pmid">21463150</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>P</given-names></name><name><surname>Wertheimer</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Oâ€™Connor</surname><given-names>CM</given-names></name><name><surname>Pina</surname><given-names>IL</given-names></name><name><surname>Selzman</surname><given-names>C</given-names></name><name><surname>Sueta</surname><given-names>C</given-names></name><name><surname>She</surname><given-names>L</given-names></name><name><surname>Greene</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><etal/></person-group>; <collab>STICH Investigators</collab>. <article-title>The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results.</article-title><source>JACC Heart Fail</source>. <year>2013</year>;<volume>1</volume>:<fpage>400</fpage>â€“<lpage>408</lpage>. <comment>doi: 10.1016/j.jchf.2013.04.012</comment><pub-id pub-id-type="pmid">24621972</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>GF</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name></person-group>. <article-title>What causes sudden death in heart failure?</article-title><source>Circ Res</source>. <year>2004</year>;<volume>95</volume>:<fpage>754</fpage>â€“<lpage>763</lpage>. <comment>doi: 10.1161/01.RES.0000145047.14691.db</comment><pub-id pub-id-type="pmid">15486322</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>RM</given-names></name><name><surname>Tedrow</surname><given-names>UB</given-names></name><name><surname>Koplan</surname><given-names>BA</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Epstein</surname><given-names>LM</given-names></name><name><surname>Sweeney</surname><given-names>MO</given-names></name><name><surname>Miller</surname><given-names>AL</given-names></name><name><surname>Michaud</surname><given-names>GF</given-names></name><name><surname>Stevenson</surname><given-names>WG</given-names></name></person-group>. <article-title>Ventricular arrhythmias and sudden cardiac death.</article-title><source>Lancet</source>. <year>2012</year>;<volume>380</volume>:<fpage>1520</fpage>â€“<lpage>1529</lpage>. <comment>doi: 10.1016/S0140-6736(12)61413-5</comment><pub-id pub-id-type="pmid">23101719</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>BY</given-names></name><name><surname>Muthupillai</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>JM</given-names></name><name><surname>Sung</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>S</given-names></name><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Elayda</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>VV</given-names></name><name><surname>Flamm</surname><given-names>SD</given-names></name></person-group>. <article-title>Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction.</article-title><source>Circulation</source>. <year>2009</year>;<volume>120</volume>:<fpage>2069</fpage>â€“<lpage>2076</lpage>. <comment>doi: 10.1161/CIRCULATIONAHA.109.852517</comment><pub-id pub-id-type="pmid">19901193</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricciardi</surname><given-names>MJ</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Davidson</surname><given-names>CJ</given-names></name><name><surname>Choi</surname><given-names>KM</given-names></name><name><surname>Klocke</surname><given-names>FJ</given-names></name><name><surname>Bonow</surname><given-names>RO</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name><name><surname>Kim</surname><given-names>RJ</given-names></name></person-group>. <article-title>Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.</article-title><source>Circulation</source>. <year>2001</year>;<volume>103</volume>:<fpage>2780</fpage>â€“<lpage>2783</lpage>. <comment>doi: 10.1161/hc2301.092121</comment><pub-id pub-id-type="pmid">11401931</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochman</surname><given-names>JS</given-names></name><name><surname>Anthopolos</surname><given-names>R</given-names></name><name><surname>Reynolds</surname><given-names>HR</given-names></name><name><surname>Bangalore</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Mavromichalis</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Contreras</surname><given-names>A</given-names></name><name><surname>Rosenberg</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Survival after invasive or conservative management of stable coronary disease.</article-title><source>Circulation</source>. <year>2023</year>;<volume>147</volume>:<fpage>8</fpage>â€“<lpage>19</lpage>. <comment>doi: 10.1161/CIRCULATIONAHA.122.062714</comment><pub-id pub-id-type="pmid">36335918</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Schuger</surname><given-names>C</given-names></name><name><surname>Beck</surname><given-names>CA</given-names></name><name><surname>Brown</surname><given-names>MW</given-names></name><name><surname>Cannom</surname><given-names>DS</given-names></name><name><surname>Daubert</surname><given-names>JP</given-names></name><name><surname>Estes</surname><given-names>NA</given-names></name><name><surname>Greenberg</surname><given-names>H</given-names></name><name><surname>Hall</surname><given-names>WJ</given-names></name><name><surname>Huang</surname><given-names>DT</given-names></name><etal/></person-group>; <collab>MADIT-RIT Trial Investigators</collab>. <article-title>Reduction in inappropriate therapy and mortality through ICD programming.</article-title><source>N Engl J Med</source>. <year>2012</year>;<volume>367</volume>:<fpage>2275</fpage>â€“<lpage>2283</lpage>. <comment>doi: 10.1056/NEJMoa1211107</comment><pub-id pub-id-type="pmid">23131066</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuger</surname><given-names>CD</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Cantillon</surname><given-names>DJ</given-names></name><name><surname>Lambiase</surname><given-names>PD</given-names></name><name><surname>Mont</surname><given-names>L</given-names></name><name><surname>Joung</surname><given-names>BY</given-names></name><name><surname>Peress</surname><given-names>D</given-names></name><name><surname>Yong</surname><given-names>P</given-names></name><name><surname>Wold</surname><given-names>N</given-names></name><name><surname>Daubert</surname><given-names>JP</given-names></name></person-group>. <article-title>Assessment of primary prevention patients receiving an ICD: systematic evaluation of ATP: APPRAISE ATP.</article-title><source>Heart Rhythm O2</source>. <year>2021</year>;<volume>2</volume>:<fpage>405</fpage>â€“<lpage>411</lpage>. <comment>doi: 10.1016/j.hroo.2021.07.003</comment><pub-id pub-id-type="pmid">34430946</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
